Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Galitzia

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Ejhaem|February 26, 2024
Myeloma's multiple morphologiesSilvia Cantoni, Andrea Galitzia, Valentina Mancini, et al.
Cancers|June 19, 2024
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted AgentsAndrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, et al.
Annals of Hematology|January 18, 2024
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosisRoberta Murru, Andrea Galitzia, Luca Barabino, et al.
Vaccines|July 27, 2022
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 VaccineAndrea Galitzia, Luca Barabino, Roberta Murru, et al.
Hemasphere|February 21, 2025
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemiaAnna Maria Frustaci, Arianna Zappaterra, Andrea Galitzia, et al.
Hematological Oncology|January 14, 2025
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life ExperienceIdanna Innocenti, Annamaria Tomasso, Diana Giannarelli, et al.
Therapeutic Advances in Hematology|October 17, 2022
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemiaAnna Maria Frustaci, Giovanni Del Poeta, Andrea Visentin, et al.
Blood Advances|April 2, 2026
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d positive CLL mainly expressed in trisomy 12Luca Laurenti, Feliciana Guglielmi, Antonio Mosca, et al.
Blood Advances|June 12, 2025
Familial Forms of Chronic Lymphocytic Leukemia Have a Worse Prognosis Than Sporadic Forms: an Italian Case-Control StudyAlberto Fresa, Idanna Innocenti, Annamaria Tomasso, et al.
Hemasphere|December 2, 2024
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experienceIdanna Innocenti, Antonio Mosca, Annamaria Tomasso, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Ejhaem|February 26, 2024
Myeloma's multiple morphologiesSilvia Cantoni, Andrea Galitzia, Valentina Mancini, et al.
Cancers|June 19, 2024
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted AgentsAndrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, et al.
Annals of Hematology|January 18, 2024
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosisRoberta Murru, Andrea Galitzia, Luca Barabino, et al.
Vaccines|July 27, 2022
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 VaccineAndrea Galitzia, Luca Barabino, Roberta Murru, et al.
Hemasphere|February 21, 2025
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemiaAnna Maria Frustaci, Arianna Zappaterra, Andrea Galitzia, et al.
Hematological Oncology|January 14, 2025
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life ExperienceIdanna Innocenti, Annamaria Tomasso, Diana Giannarelli, et al.
Therapeutic Advances in Hematology|October 17, 2022
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemiaAnna Maria Frustaci, Giovanni Del Poeta, Andrea Visentin, et al.
Blood Advances|April 2, 2026
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d positive CLL mainly expressed in trisomy 12Luca Laurenti, Feliciana Guglielmi, Antonio Mosca, et al.
Blood Advances|June 12, 2025
Familial Forms of Chronic Lymphocytic Leukemia Have a Worse Prognosis Than Sporadic Forms: an Italian Case-Control StudyAlberto Fresa, Idanna Innocenti, Annamaria Tomasso, et al.
Hemasphere|December 2, 2024
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experienceIdanna Innocenti, Antonio Mosca, Annamaria Tomasso, et al.
Pageof 2